Importantly, Lphn3 gene deficient animals were responsive to psychostimulant medication used for the treatment of ADHD, thus indicating that the experimentally-created condition depending on Lphn3 expression generates important pathological aspects reminiscent of clinical manifestations of the disorder [31, 34]. The gene discussed is ADGRL3; the disease is attention deficit-hyperactivity disorder.